DGDeborah Gustafson

Deborah Gustafson

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Deborah Gustafson has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Depression in Swedish women: relationship to factors at birth

    by Pia Gudmundsson, Susan Andersson, Deborah Gustafson, Margda Waern, Svante Östling, Tore Hällström, Sigurdur Palsson, Ingmar Skoog, Lena Hulthen

    Depression is a common and serious disorder that may have developmental origins. Birth-related factors have been related to childhood and adult occurrence of somatic as well as psychiatric disorders, but studies on the relationship between birth-related factors and depression are few and show mixed results. In addition, varying methods have been used to assess depression. Standardized clinical criteria to diagnose depression, combined with birth data collected from midwife records have not been used in most studies. Participants in the Prospective Population Study of Women in Sweden (803 women), born 1914, 1918, 1922 and 1930, provide information on birth factors and depression. Women participated from 1968 at mid-life ages of 38–60 years, to 2000, when they were age 78–92 years. Original birth records containing birth weight, length, head circumference, and gestational time, as well as social factors were obtained. Lifetime depression was diagnosed via multiple information sources. Symptoms were assessed using the Comprehensive Psychopathological Rating Scale and diagnoses were based on DSM-III-R criteria. Over their lifetime, 44.6% of women in this sample experienced depression. Birth weights ≤ 3500 g [odds ratio (OR), age-adjusted = 1.72; 95% CI 1.29–2.28, P < 0.001] and shorter gestational time (OR, age-adjusted = 1.13; 95% CI 1.04–1.24, P = 0.005) were independently associated with a higher odds of lifetime depression in a logistic regression model adjusted for age. Lower than median birth weights and shorter gestational time were related to lifetime depression in women. Both neurodevelopmental and environmental contributions to lifetime depression may be considered.


  • Mid‐life adiposity factors relate to blood–brain barrier integrity in late life

    by D. R. Gustafson, C. Karlsson, I. Skoog, L. Rosengren, L. Lissner, K. Blennow

    Abstract.  Gustafson DR, Karlsson C, Skoog I, Rosengren L, Lissner L, Blennow K (Gothenburg University, Gothenburg, Sweden; and Medical College of Wisconsin, Milwaukee, WI, USA). Mid‐life adiposity factors relate to blood–brain barrier integrity in late life. J Intern Med 2007; 262: 643–650.Objective.  We explored the relationship between adiposity factors measured during mid‐life and blood–brain barrier (BBB) integrity measured via the cerebrospinal fluid/serum (CSF/S) albumin ratio in late life. Adiposity factors included body mass index and blood levels of sex hormone binding globulin (SHBG) and leptin.Design.  Retrospective analyses over 24 years within a longitudinal study.Setting.  Population‐based sample.Subjects.  Eighty‐one women.Main outcome measures.  CSF/S albumin ratio.Results.  The CSF/S albumin ratio measured at age 70–84 years was higher amongst women who were overweight or obese (6.50 ± 2.79 vs. 5.23 ± 1.61, age‐adjusted P = 0.012), and was inversely correlated with SHBG (age‐adjusted r = −0.321, P < 0.005) at age 46–60 years. In stepwise regression models, SHBG predicted the CSF/S albumin ratio (beta = −0.017, R2 = 0.107, P = 0.007). The best model (R2 = 0.187) predicting CSF/S albumin ratio included SHBG, age group (age 46 years versus >46), overweight or obesity, and an age group by SHBG interaction.Conclusions.  Lower levels of SHBG in mid‐life were related to worse BBB integrity in women after 24 years in late life, even considering other adiposity factors. SHBG may be important for understanding sex hormone‐mediated mechanisms in brain health or as an independent marker of adipose tissue, the largest endocrine organ.


  • Cerebrospinal fluid -amyloid 1-42 concentration may predict cognitive decline in older women

    by Deborah R Gustafson, Ingmar Skoog, Lars Rosengren, Henrik Zetterberg, Kaj Blennow

    Background: Low levels of cerebrospinal fluid (CSF) β-amyloid 1–42 (Aβ42) and high total tau (T-tau) are diagnostic for manifest Alzheimer’s disease. It is not known, however, whether these biomarkers may be risk indicators for cognitive decline in otherwise healthy older people. Methods: The longitudinal relationship between CSF markers, Aβ42 and T-tau, measured in 1992, and change in Mini-Mental State Examination (ΔMMSE) score between 1992 and 2002 were investigated in 55 women (aged 70–84 years, mean (SD) MMSE score = 28.3 (1.5)), who were participants in the Prospective Population Study of Women in Gothenburg, Sweden. These women did not have dementia when they experienced lumbar puncture in 1992–3. Results: Over the 8-year follow-up period, ΔMMSE (range = +3 to −21 points) was correlated with Aβ42 (Spearman’s r = 0.40, p = 0.002), such that lower levels of Aβ42 were related to greater decline. This was also observed after excluding 4 women who developed dementia between 1992 and 2002 (Spearman’s r = 0.34, p = 0.019). A multivariate logistic regression model predicting a decline of ⩾5 points on the MMSE (observed in six women), or a risk of developing dementia over the 8-year follow-up period (observed in four women), including age, education, Aβ42 and T-tau as covariates, showed that Aβ42 was the sole predictor of significant cognitive decline or dementia (OR per 100 pg/ml Aβ42 = 2.24, 95% CI 1.19 to 4.22, p = 0.013). Conclusions: Low levels of CSF Aβ42 may predict cognitive decline among older women without dementia.


  • A 24-year follow-up of body mass index and cerebral atrophy

    by D. Gustafson, L. Lissner, C. Bengtsson, C. Björkelund, I. Skoog

    Objective: To investigate the longitudinal relationship between body mass index (BMI), a major vascular risk factor, and cerebral atrophy, a marker of neurodegeneration, in a population-based sample of middle-aged women. Methods: A representative sample of 290 women born in 1908, 1914, 1918, and 1922 was examined in 1968 to 1969, 1974 to 1975, 1980 to 1981, and 1992 to 1993 as part of the Population Study of Women in Göteborg, Sweden. At each examination, women completed a survey on a variety of health and lifestyle factors and underwent anthropometric, clinical, and neuropsychiatric assessments and blood collection. Atrophy of the temporal, frontal, occipital, and parietal lobes was measured on CT in 1992 when participants were age 70 to 84. Univariate and multivariate regression analyses were used to assess the relationship between BMI and brain measures. Results: Women with atrophy of the temporal lobe were, on average, 1.1 to 1.5 kg/m2 higher in BMI at all examinations than women without temporal atrophy (p < 0.05). Multivariate analyses showed that age and BMI were the only significant predictors of temporal atrophy. Risk of temporal atrophy increased 13 to 16% per 1.0-kg/m2 increase in BMI (p < 0.05). There were no associations between BMI and atrophy measured at three other brain locations. Conclusion: Overweight and obesity throughout adult life may contribute to the development of temporal atrophy in women.


  • Open Access

    An 18-Year Follow-up of Overweight and Risk of Alzheimer Disease

    by Deborah Gustafson, Elisabet Rothenberg, Kaj Blennow, Bertil Steen, Ingmar Skoog

    OVERWEIGHT AND obesity are increasing at epidemic proportions among Western societies.1,2 The prevalence of overweight and obesity is more than 50% among adults in the United States and Europe,2,3 with the highest prevalence observed among adults 50 years and older.2,3 Dementia is also a major public health problem that will continue to increase rapidly as people live to older ages. By age 85 years, the incidence of dementia approaches 10%,4 and its prevalence is approximately 30%.5 The most common form of dementia is Alzheimer disease (AD), a degenerative dementia. Vascular dementia (VaD), the second most common dementia, is a direct consequence of cerebrovascular disorders. Recently, however, several studies suggest that there may be an association between AD and vascular disorders, such as atherosclerosis,6 hypertension, coronary heart disease, and diabetes mellitus.7 Since overweight and obesity increase risk of vascular disorders,8 overweight and obesity may be risk factors for both AD and VaD. Surprisingly, few studies have examined this hypothesis.